在DNA纳米载体上进行小分子药物的非共价和精确加载
Xinyu Feng1, Mingtao Zhao2, Huichao Chen1
1School of Pharmacy, Key Laboratory of Anti-inflammatory and Immune Medicine, Ministry of Education, Institute of Clinical Pharmacology, Anhui Medical University, Hefei 230032, China. sunwuyi51@aliyun.com.
Nanoscale horizons
|November 26, 2025
概括
研究人员开发了一种新的非共价方法,用于使用基配对将小分子药物加载到DNA纳米载体上. 这一进步使得有效的药物输送和协同疗法成为可能,在黑色素瘤治疗中显示出前景.
科学领域:
- 生物技术是生物技术.
- 纳米医学是一种纳米医学.
- 分子生物学分子生物学
背景情况:
- DNA纳米载体为药物输送提供可编程结构和生物相容性.
- 将小分子药物加载到DNA纳米载体上具有挑战性,通常需要复杂的化学合成.
- 现有的方法限制了可以集成的小分子药物的类型.
研究的目的:
- 开发一种非共价方法,用于精确地将小分子药物加载到DNA纳米载体上.
- 克服目前用于核酸纳米载体的药物整合技术的局限性.
- 为了证明装载在DNA纳米结构上的小分子药物的治疗效果.
主要方法:
- 利用小分子介导的非正规基配对用于药物集成.
- 开发了APTAMER功能化的DNA纳米粒子,用于有针对性的输送.
- 将cordycepin作为一种模型小分子药物装载到DNA纳米载体上.
主要成果:
- 成功地实现了cordycepin在DNA纳米载体上的非共价和精确加载.
- 在患有黑色素瘤的小鼠中表现出显著的治疗效果.
- 扩大了DNA纳米结构的适用性,用于小分子药物输送.
结论:
- 这种新型的非共价加载方法扩大了可用DNA纳米载体的药物范围.
- 这种方法促进了结合小分子和核酸药物的协同疗法.
- 这些发现代表了纳米医学在癌症治疗中的重大进步.
更多相关视频
09:41Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
Published on: February 25, 2021
24.9K
10:05Genome-wide Mapping of Drug-DNA Interactions in Cells with COSMIC Crosslinking of Small Molecules to Isolate Chromatin
Published on: January 20, 2016
8.6K
相关概念视频
Drug-Receptor Bonds
4.2K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
4.2K
Labeling DNA Probes
9.2K
DNA probes are fragments of DNA labeled with a reporter tag to enable their detection or purification. The resulting labeled DNA probes can then hybridize to target nucleic acid sequences through complementary base-pairing, and may be used to recover or identify these regions.
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
Radioisotopes, fluorophores, or small molecule binding partners like biotin or digoxigenin, are the most widely used reporter tags for labeling DNA probes. These labels can be attached to the probe DNA molecule via...
9.2K
